Cat.#: ACPP-1318
| Despition | Orexin A Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1196 | Insulin Receptor beta Blocking Peptide (AC1196) | 250 µg | inquiry |
| ACPP-1828 | Human EPHA2 Protein (AC1828) | 2 µg | inquiry |
| ACPP-1437 | Human LINGO1 Protein (AC1437) | 5 µg | inquiry |
| ACPP-1094 | Recombinant Human FGFR4 Protein (Functional) (AC1094) | 10 µg | inquiry |
| ACPP-1725 | Human GHRL Protein (AC1725) | 1 mg | inquiry |
| ACPP-1637 | Human NRN1 Protein, His (AC1637) | 2 µg | inquiry |
| ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
| ACPP-1100 | Synthetic Membrane Nanoparticle Human Somatostatin Receptor 2 Protein (AC1100) | 50 µg | inquiry |
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
| ACPP-1406 | Human Recoverin Protein (AC1406) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.